Skip to main content
. 2020 Aug 20;11:4168. doi: 10.1038/s41467-020-17965-0

Fig. 4. Survival and time to treatment failure in PBRM1 mutated MSKCC ccRCC patients.

Fig. 4

Kaplan–Meier curves demonstrating overall survival (median 68.2 months; 95% CI 44.4, NA) and time-to-treatment failure (TTF) (median 8.9 months; 95% CI 6.9, 12.42) in clear cell RCC patients across MSK-IMPACT.